| Literature DB >> 24333256 |
Carsten Goebel1, John Troutman2, Jenny Hennen3, Helga Rothe4, Harald Schlatter4, G Frank Gerberick2, Brunhilde Blömeke3.
Abstract
The strong sensitizing potencies of the most important primary intermediates of oxidative hair dyes, p-phenylenediamine (PPD) and p-toluylenediamine (PTD, i.e. 2-methyl-PPD) are well established. They are considered as the key sensitizers in hair dye allergic contact dermatitis. While modification of their molecular structure is expected to alter their sensitizing properties, it may also impair their color performance. With introduction of a methoxymethyl side chain we found the primary intermediate 2-methoxymethyl-p-phenylenediamine (ME-PPD) with excellent hair coloring performance but significantly reduced sensitizing properties compared to PPD and PTD: In vitro, ME-PPD showed an attenuated innate immune response when analyzed for its protein reactivity and dendritic cell activation potential. In vivo, the effective concentration of ME-PPD necessary to induce an immune response 3-fold above vehicle control (EC3 value) in the local lymph node assay (LLNA) was 4.3%, indicating a moderate skin sensitizing potency compared to values of 0.1 and 0.17% for PPD and PTD, respectively. Finally, assessing the skin sensitizing potency of ME-PPD under consumer hair dye usage conditions through a quantitative risk assessment (QRA) indicated an allergy induction risk negligible compared to PPD or PTD.Entities:
Keywords: 2,4-dinitrochlorobenzene; 2-Methoxymethyl-p-phenylenediamine; 2-methoxymethyl-p-phenylenediamine; Alternative methods; DC; DMSO; DNCB; HE-PPD; HRP/P; Hair dyes; Innate immune response; LLNA; ME-PPD; MEL; NESIL; PPD; PTD; QRA; SCCS; SI; Scientific Committee on Consumer Safety; Skin metabolism; Skin sensitization; WoE; dendritic cell; dimethylsulfoxide; horseradish peroxidase and hydrogen peroxide; hydroxyethyl-PPD; local lymph node assay; measured exposure level; no expected sensitization induction level; p-phenylenediamine; p-toluylenediamine; quantitative risk assessment; stimulation index; weight-of-evidence
Mesh:
Substances:
Year: 2013 PMID: 24333256 DOI: 10.1016/j.taap.2013.11.016
Source DB: PubMed Journal: Toxicol Appl Pharmacol ISSN: 0041-008X Impact factor: 4.219